Search

everythinglearnresearchcommunity

for

Search:↓

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

Hormonal imbalances in Polycystic Ovarian Syndrome (PCOS) might trigger a rare skin disorder called Confluent and Reticulated Papillomatosis (CRP), so dermatologists should consider checking for PCOS in CRP patients.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.

PCOS care in Singapore can be bettered by refining referral systems, standardizing diagnosis and treatment, enhancing complication screening, and offering educational resources for clinicians.

Mutations in mitochondrial DNA might significantly contribute to the development of Polycystic Ovarian Syndrome.

A woman's high testosterone levels and related symptoms improved after ovary removal surgery.

A special blood test helped find the overactive ovary in a teen with PCOS, and removing that ovary improved her condition.

More young women are getting diagnosed with PCOS, which can lead to other health problems, but early treatment can help.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.